Dr Ian Hudson has commenced his appointment as the new Chief Executive of the Medicines and Healthcare Products Regulatory Agency. Dr Hudson replaces former Chief Executive Professor Sir Kent Woods who has stepped down after ten years with the Agency. Dr Hudson was previously the MHRA’s Director of Licensing for 12 years, responsible for the majority of medicines licensing activities in the UK. This followed a career as a physician, specialising in paediatrics as well as time spent in the pharmaceutical industry working in clinical research and drug development.
The Agency’s Chairman, Sir Gordon Duff said: “Ian has excellent, broad experience across all aspects of medicines regulation and is ideally placed to lead our Agency, which is unique in bringing together medicines and medical devices regulation together with world-class research facilities and expertise.”
Dr Hudson said: “I’m delighted to be appointed to the role of Chief Executive. The Agency plays a critical role in ensuring that medicines and medical devices help people and are acceptably safe; we support research and development; and protect and promote the health of millions of people through our activities. Sir Kent has led the Agency very effectively and has developed it into one of the leading medicines and medical devices regulators in the world. I am proud to have been selected to succeed him.”